Stryker declares a $0.63 per share quarterly dividend
Stryker (NYSE:SYK) announced a quarterly dividend of $0.63 per share, payable on October 29, 2021, to shareholders of record as of September 30, 2021.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Stryker (NYSE:SYK) announced a quarterly dividend of $0.63 per share, payable on October 29, 2021, to shareholders of record as of September 30, 2021. This reflects a 9.6% increase compared to the previous year and remains unchanged from the last quarter. Stryker is a prominent player in the medical technology sector, focusing on enhancing healthcare through innovative products and services across various specialties including Orthopaedics, Medical and Surgical, and Neurotechnology.
Positive
- Quarterly dividend increased by 9.6% compared to the previous year
- Dividend remains consistent from the previous quarter, indicating stable cash flow
Negative
- None.
Details
News Market Reaction – SYK
The recorded move for SYK in the trading session of this news was -2.03%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Kalamazoo, Michigan, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of
Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.
Contacts
For investor inquiries please contact:
Preston Wells, Vice President, Investor Relations at 269-385-2600 or preston.wells@stryker.com
For media inquiries please contact:
Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or yin.becker@stryker.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.